Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 15, 2007

Unigene Gets Funding for Novel Peptide Hormone Therapies

  • Unigene Laboratories received a $900,000 funding to advance it’s discovery program related to therapeutic peptide hormones. The phase II SBIR grant from the National Institute for Diabetes and Digestive Kidney Diseases will be provided over two years.

    In 2003, Unigene received a phase I grant, which allowed the company to utilize the technology it developed in collaboration with the University of South Florida to establish a procedure for identifying such peptides in various plant or animal tissues.

    "An increasing number of peptides are being shown to play essential roles in fundamental human metabolic processes, yet only a small number of these have already been commercialized,” states Ronald S. Levy, M.D., executive vp of Unigene. “This program can create additional opportunities for the utilization of Unigene's peptide manufacturing and delivery technologies, while enabling us to obtain additional patent protection on the novel peptides themselves."



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »